Sort
16,300 grants matching “fatty liver disease”
Development of caspase-6 inhibitors for treatment of NASH
$671,821Alan R. Saltiel · University Of California, San Diego · R01 · FY2024 · DK
Metabolic Health during Puberty: the Healthy Start Study
$671,757Dana Dabelea · University Of Colorado Denver · R01 · FY2024 · DK
Role of liver and visceral fat in glucose and lipid metabolism during pregnancy
$671,559Kimberly Kristine Vesco · Kaiser Foundation Research Institute · R01 · FY2015 · DK
A PSGL-1 Glycopeptide Mimetic for Treatment of Metabolic Syndrome
$671,542Elliot Chaikof · Beth Israel Deaconess Medical Center · R01 · FY2017 · DK
Project 3: Non-invasive assessment of liver fibrosis stage and progression in obesity and diabetes: a Hispanic population study
$671,469Laura Beretta · University Of Tx Md Anderson Can Ctr · P50 · FY2021 · CA
Human population based genetic studies to elucidate the biology of NAFLD
$671,469Elizabeth K Speliotes · University Of Michigan At Ann Arbor · R01 · FY2018 · DK
Role of liver and visceral fat in glucose and lipid metabolism during pregnancy
$671,284Kimberly Kristine Vesco · Kaiser Foundation Research Institute · R01 · FY2014 · DK
Mediators of Atherosclerosis in South Asians Living in America
$671,125Alka M Kanaya · University Of California, San Francisco · R01 · FY2017 · HL
A population-based study of deep learning derived organ and tissue measures for accelerated aging using repurposed abdominal CT images
$670,589Andrew D Rule · Mayo Clinic Rochester · R01 · FY2024 · AG
A population-based study of deep learning derived organ and tissue measures for accelerated aging using repurposed abdominal CT images
$670,588Andrew D Rule · Mayo Clinic Rochester · R01 · FY2023 · AG
Modulation of cancer induced immune suppression via inhibition of SCD1
$670,441Karen E Hayes · Modulation Therapeutics, Inc. · R44 · FY2024 · CA
Role of IRF3 in Energy and Glucose Homeostasis
$670,248Evan D Rosen · Beth Israel Deaconess Medical Center · R01 · FY2020 · DK
Calorie restriction and aging
$670,041Rafael De Cabo · National Institute On Aging · ZIA · FY2019 · AG
Treating early type 2 diabetes by reducing postprandial glucose excursions: A paradigm shift in lifestyle modification
$670,034Chiara Fabris · University Of Virginia · R01 · FY2024 · DK
Homeostatic Responses to Amino Acid Insufficiency
$669,968Tracy G. Anthony · Rutgers, The State Univ Of N.J. · R01 · FY2022 · DK
Modeling and Characterization of NAFLD Phenotypes in a Severely Affected Family
$669,949Aras Nikodemas Mattis · University Of California, San Francisco · R01 · FY2024 · DK
Novel Biomarkers for Post-Liver Transplant NASH Fibrosis
$669,821Gavin E Arteel · University Of Pittsburgh At Pittsburgh · R01 · FY2024 · DK
Rabbit model for cystic fibrosis
$669,737Fei Sun · Wayne State University · R01 · FY2017 · HL
Rabbit model for cystic fibrosis
$669,737Jian-Ping Jin · Wayne State University · R01 · FY2019 · HL
Surgical or Medical Treatment for Pediatric Type 2 Diabetes (ST2OMP)
$669,713Michael A Helmrath · Cincinnati Childrens Hosp Med Ctr · R01 · FY2020 · DK
Mechanisms Regulating Neurotensin Secretion and Function
$669,684Bernard Mark Evers · University Of Kentucky · R01 · FY2022 · DK
Mechanisms Regulating Neurotensin Secretion and Function
$669,684Bernard Mark Evers · University Of Kentucky · R01 · FY2025 · DK
Mechanisms Regulating Neurotensin Secretion and Function
$669,684Bernard Mark Evers · University Of Kentucky · R01 · FY2023 · DK
Mechanisms of adipocyte loss in laminopathy-induced lipodystrophy in mice and humans
$669,659Ormond A Macdougald · University Of Michigan At Ann Arbor · R01 · FY2024 · DK
Homeostatic Responses to Amino Acid Insufficiency
$669,484Tracy G. Anthony · Rutgers, The State Univ Of N.J. · R01 · FY2023 · DK